Author/Authors :
Eftekhari، Mohammad نويسنده Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, , , Anbiaei ، Robabeh نويسنده Department of Radiation Oncology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, , , Zamani، Hanie نويسنده Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, , , Fallahi ، Babak نويسنده Associate Professor, Department of Nuclear Medicine, School of Medicine, Shariati/Nuclear medicine, Tehran University of Medical Sciences. Tehran, Ira , , BEIKI، Davood نويسنده , , Ameri، Ahmad نويسنده Department of Radiation Oncology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, , , Emami-Ardekani، Alireza نويسنده Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, , , Fard-Esfahani، Armaghan نويسنده Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, , , Gholamrezanezhad، Ali نويسنده Research Center for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, , , Razavi-ratki، Seid Kazem نويسنده MD, Nuclear Medicine Specialist, Department of Nuclear Medicine, Shahid Sadooghi University of Medical Sciences, Yazd, Iran , , Momen Roknabadi ، Alireza نويسنده Department of Radiation Oncology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, ,
Abstract :
Objective(s): Radiation therapy for breast cancer can induce myocardial capillary injury and
increase cardiovascular morbidity and mortality. A prospective cohort was conducted to study
the prevalence of myocardial perfusion abnormalities following radiation therapy of left-sided
breast cancer patients as compared to those with right–sided cancer.
Methods: To minimize potential confounding factors, only those patients with low 10-year
risk of coronary artery disease (based on Framingham risk scoring) were included. All
patients were initially treated by modified radical mastectomy and then were managed by
postoperative 3D Conformal Radiation Therapy (CRT) to the surgical bed with an additional
1-cm margin, delivered by 46-50 Gy (in 2 Gy daily fractions) over a 5-week course. The same
dose-adjusted chemotherapy regimen (including anthracyclines, cyclophosphamide and
taxol) was given to all patients. Six months after radiation therapy, all patients underwent
cardiac SPECT for the evaluation of myocardial perfusion.
Results: A total of 71 patients with a mean age of 45.3±7.2 years [35 patients with leftsided
breast cancer (exposed) and 36 patients with right-sided cancer (controls)] were enrolled.
Dose-volume histogram (DVH) [showing the percentage of the heart exposed to > 50%
of radiation] was significantly higher in patients with left-sided breast cancer. Visual
interpretation detected perfusion abnormalities in 42.9% of cases and 16.7% of controls
(P=0.02, Odds ratio=1.46). In semiquantitative segmental analysis, only apical (28.6% versus
8.3%, P=0.03) and anterolateral (17.1% versus 2.8%, P=0.049) walls showed significantly
reduced myocardial perfusion in the exposed group. Summed Stress Score (SSS) of > 3 was
observed in twelve cases (34.3%), while in five of the controls (13.9%),(Odds ratio=1.3). There
was no significant difference between the groups regarding left ventricular ejection fraction.
Conclusion: The risk of radiation induced myocardial perfusion abnormality in patients
treated with CRT on the left hemi thorax is not low. It is reasonable to minimize the volume of
the heart being in the field of radiation employing didactic radiation planning techniques. Also
it is advisable to screen these patients with MPI-SPECT, even if they are clinically asymptomatic,
as early diagnosis and treatment of silent ischemia may change the outcome.